Data / Drug companies / Novo Nordisk A/s
Novo Nordisk A/s: 22 products in the FDA NDC directory, labeler code 0420
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Novo Nordisk A/s (labeler code 0420) lists 22 products in the FDA National Drug Code Directory. By type: 12 bulk ingredients, 10 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on May 7, 2026.
The request: Watch Novo Nordisk A/s (FDA labeler code 0420): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0420
- Products in commercial distribution
- 22
- Packages
- 26
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 5
- Earliest marketing start
- March 10, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 12 | 54.5% |
| Drugs for further processing | 10 | 45.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 12 | 54.5% |
| Drugs for further processing | 10 | 45.5% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 7 | 31.8% |
| Crystal | 6 | 27.3% |
| Powder | 4 | 18.2% |
| Tablet | 3 | 13.6% |
| Gel | 1 | 4.5% |
| Solution | 1 | 4.5% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Semaglutide | 0420-9301 | Injection, solution | Drugs for further processing | May 7, 2026 |
| Semaglutide | 0420-9600 | Injection, solution | Drugs for further processing | April 29, 2026 |
| Semaglutide | 0420-9324 | Injection, solution | Drugs for further processing | April 28, 2026 |
| Semaglutide | 0420-9317 | Injection, solution | Drugs for further processing | April 28, 2026 |
| Semaglutide | 0420-9302 | Injection, solution | Drugs for further processing | April 28, 2026 |
| Semaglutide | 0420-9511 | Powder | Bulk ingredients | November 10, 2021 |
| Semaglutide snac | 0420-9540 | Tablet | Drugs for further processing | September 20, 2019 |
| Semaglutide snac | 0420-9530 | Tablet | Drugs for further processing | September 20, 2019 |
| Semaglutide snac | 0420-9520 | Tablet | Drugs for further processing | September 20, 2019 |
| Semaglutide | 0420-9237 | Injection, solution | Drugs for further processing | December 6, 2017 |
| Semaglutide | 0420-9008 | Powder | Bulk ingredients | December 6, 2017 |
| Semaglutide | 0420-9300 | Injection, solution | Drugs for further processing | June 2, 2017 |
| Degludec | 0420-9007 | Powder | Bulk ingredients | July 20, 2012 |
| Liraglutide | 0420-9006 | Powder | Bulk ingredients | February 1, 2011 |
| Benzalkonium chloride | 0420-1202 | Solution | Bulk ingredients | October 15, 2010 |
| Insulin aspart | 0420-9010 | Crystal | Bulk ingredients | March 25, 2010 |
| Insulin aspart | 0420-9000 | Crystal | Bulk ingredients | March 25, 2010 |
| Insulin detemir | 0420-9013 | Crystal | Bulk ingredients | March 24, 2010 |
| Insulin recombinant human | 0420-9005 | Crystal | Bulk ingredients | March 24, 2010 |
| Insulin recombinant human | 0420-9004 | Crystal | Bulk ingredients | March 24, 2010 |
| Insulin detemir | 0420-9003 | Crystal | Bulk ingredients | March 24, 2010 |
| Benzalkonium chloride | 0420-1201 | Gel | Bulk ingredients | March 10, 2010 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.